T Cell Therapy for Acute Lymphoblastic Leukemia: Results as of November 2013

CTL019 is a clinical trial of T cell therapy for patients with B cell cancers such as acute lymphoblastic leukemia (ALL), B cell non-Hodgkin lymphoma (NHL), and the adult disease chronic lymphocytic leukemia (CLL). At this time, The Children's Hospital of Philadelphia is the only hospital enrolling pediatric patients on this trial. Scientists at The Children's Hospital of Philadelphia and the University of Pennsylvania are very hopeful that CTL019 could in the future be an effective therapy for patients with B cell cancers.

[@umajunkcollector]

I hope and pray that this works as a major breakthrough in overcoming cancer!

[@althiramakrishna2308]

Sir,it comes to india with low price ,its helped to so many lives

[@patrakentung]

if doctor can do this in Indonesia, perhaps it's can be helped the cancer patient .. T Cell better than chemotherapy

[@almirbarbosasantos5551]

Can this treatment user for sarcoma?

[@ramonlujan4070]

My six year son has ALL T-cell and also muscular dystrophy Duchenne would it work for this clinical trial

[@joshuamartin4123]

Any results

[@nburvi1]

5 years cancer free!